Literature DB >> 10472326

Change in telomerase activity during human colorectal carcinogenesis.

R Yoshida1, Y Kiyozuka, H Ichiyoshi, H Senzaki, H Takada, K Hioki, A Tsubura.   

Abstract

Telomerase activities in endoscopically resected colorectal adenomas, surgically resected colorectal cancers and adjacent normal colonic mucosa were examined semiquantitatively by a polymerase chain reaction-based telomeric repeat amplification protocol (TRAP) assay. All normal mucosa (n = 15) presented weak telomerase activity (mean +/- SE: 0.99 +/- 0.00). When the value of 1.00 was arbitrary given to the mean activity of normal mucosa, the telomerase activity in the adenomas (n = 14) was up-regulated (2.01 +/- 0.22) relative to the normal mucosa. The telomerase activity in the high-grade atypia (severe atypia and carcinoma in situ) (2.58 +/- 0.34) was significantly higher than that in the low-grade (mild and moderate) atypia (1.59 +/- 0.18) (P < 0.05), and the adenomas 10 mm or more in diameter presented significantly higher telomerase activity (2.56 +/- 0.09) than compared to the smaller ones (1.44 +/- 0.17) (p < 0.05). Carcinomas (n = 20), showed a telomerase activity that varied from 0.97 to 16.93, which was than the greater mean telomerase activity (6.96 +/- 1.25) noted in the adenomas. The telomerase activity in the carcinomas tended to be higher in the larger (> or = 4 cm), histologically less-differentiated (moderately differentiated), late-stage (Dukes C + D), and nodal metastatic tumors, suggestive of unfavorable prognosis. These results suggests that the weak telomerase activity in normal colonic mucosa is gradually activated during the course of colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472326

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Invasive carcinomas may arise in colorectal adenomas with high-grade dysplasia and with carcinoma in situ.

Authors:  Carlos A Rubio; John G Delinassios
Journal:  Int J Clin Exp Med       Date:  2010-01-08

2.  Differences in telomerase activity between colon and rectal cancer.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Adamantia Zizi-Sermpetzoglou; Maria Georgiadou; Ourania Sfakianaki; Elias Kouroumallis
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

3.  Short rare hTERT-VNTR2-2nd alleles are associated with prostate cancer susceptibility and influence gene expression.

Authors:  Se-Lyun Yoon; Se-Il Jung; Eun-Ju Do; Se-Ra Lee; Sang-Yeop Lee; In-Sun Chu; Wun-Jae Kim; Jaeil Jung; Choung Soo Kim; Sang-Hyeon Cheon; Sun-Hee Leem
Journal:  BMC Cancer       Date:  2010-07-26       Impact factor: 4.430

4.  Telomerase activity in chronic inflammatory bowel disease.

Authors:  Elke Kleideiter; Ulrike Friedrich; Alexandra Möhring; Siegfried Walker; Emil Höring; Karlernst Maier; Peter Fritz; Klaus-Peter Thon; Ulrich Klotz
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

5.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

6.  Detection of circulating carcinoma cells by telomerase activity.

Authors:  L R Gauthier; C Granotier; J C Soria; S Faivre; V Boige; E Raymond; F D Boussin
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

Review 7.  Telomere and Telomerase Therapeutics in Cancer.

Authors:  Yucheng Xu; Amir Goldkorn
Journal:  Genes (Basel)       Date:  2016-05-26       Impact factor: 4.096

8.  Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.

Authors:  Leila Vania; Gavin Morris; Eloise Ferreira; Stefan F T Weiss
Journal:  BMC Cancer       Date:  2021-04-09       Impact factor: 4.430

9.  Novel Prognostic Biomarkers in Metastatic and Locally Advanced Colorectal Cancer: Micronuclei Frequency and Telomerase Activity in Peripheral Blood Lymphocytes.

Authors:  Taxiarchis Konstantinos Nikolouzakis; Elena Vakonaki; Polychronis D Stivaktakis; Athanasios Alegakis; Aikaterini Berdiaki; Nikolaos Razos; John Souglakos; Aristidis Tsatsakis; John Tsiaoussis
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

Review 10.  An introduction to telomeres and telomerase.

Authors:  Michael C Bibby
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.